Healthcare provider profile · identity verified

John D Sestero, M.D.

Internal Medicine · SPOKANE VALLEY, WA · NPI 1356359475

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	174
Levothyroxine Sodium	Levothyroxine Sodium	549	141
Amlodipine Besylate	Amlodipine Besylate	469	134
Lisinopril	Lisinopril	338	99
Omeprazole	Omeprazole	298	95
Losartan Potassium	Losartan Potassium	283	78
Rosuvastatin Calcium	Rosuvastatin Calcium	220	68
Tamsulosin Hcl	Tamsulosin Hcl	199	63
Potassium Chloride	Potassium Chloride	191	60
Metformin Hcl Er	Metformin Hcl	171	50
Simvastatin	Simvastatin	164	43
Gabapentin	Gabapentin	152	42
Eliquis	Apixaban	151	36
Albuterol Sulfate Hfa	Albuterol Sulfate	128	46
Trazodone Hcl	Trazodone Hcl	128	34
Carvedilol	Carvedilol	127	31
Allopurinol	Allopurinol	120	32
Pravastatin Sodium	Pravastatin Sodium	119	37
Hydrochlorothiazide	Hydrochlorothiazide	118	39
Sertraline Hcl	Sertraline Hcl	116	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	28
Metoprolol Succinate	Metoprolol Succinate	108	36
Pantoprazole Sodium	Pantoprazole Sodium	108	43
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	107	32
Tramadol Hcl	Tramadol Hcl	99	28
Metformin Hcl	Metformin Hcl	97	29
Duloxetine Hcl	Duloxetine Hcl	91	20
Escitalopram Oxalate	Escitalopram Oxalate	91	28
Furosemide	Furosemide	89	31
Meloxicam	Meloxicam	84	31
Synthroid	Levothyroxine Sodium	79	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	21
Metoprolol Tartrate	Metoprolol Tartrate	76	19
Ozempic	Semaglutide	68	14
Montelukast Sodium	Montelukast Sodium	67	20
Irbesartan	Irbesartan	65	17
Glipizide Er	Glipizide	63	17
Telmisartan	Telmisartan	60	17
Citalopram Hbr	Citalopram Hydrobromide	59	16
Spironolactone	Spironolactone	59	16
Zolpidem Tartrate	Zolpidem Tartrate	58	15
Bupropion Xl	Bupropion Hcl	56	20
Donepezil Hcl	Donepezil Hcl	53	12
Jardiance	Empagliflozin	52	12
Ezetimibe	Ezetimibe	51	16
Fluoxetine Hcl	Fluoxetine Hcl	51	16
Fluticasone Propionate	Fluticasone Propionate	49	19
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Celecoxib	Celecoxib	47	14
Alendronate Sodium	Alendronate Sodium	45	12
Famotidine	Famotidine	44	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	13
Memantine Hcl	Memantine Hcl	42	suppressed
Benazepril Hcl	Benazepril Hcl	38	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	11
Mounjaro	Tirzepatide	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Ipratropium Bromide	Ipratropium Bromide	34	11
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	34	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	11
Estradiol	Estradiol	33	suppressed
Prednisone	Prednisone	32	19
Valsartan	Valsartan	32	11
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	19
Glimepiride	Glimepiride	30	suppressed
Atenolol	Atenolol	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Felodipine Er	Felodipine	25	suppressed
Lorazepam	Lorazepam	25	11
Alprazolam	Alprazolam	24	11
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Finasteride	Finasteride	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Ramipril	Ramipril	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	14
Eszopiclone	Eszopiclone	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Testosterone	Testosterone	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error